|
Volumn 1027, Issue 1-2, 2004, Pages 93-102
|
Complementary use of gas chromatography-mass spectrometry, gas chromatography-atomic emission detection and nuclear magnetic resonance for identification of pharmaceutically related impurities of unknown structures
|
Author keywords
Dichloro(difluoromethoxy)benzene; Pharmaceutical analysis
|
Indexed keywords
GAS CHROMATOGRAPHY;
IMPURITIES;
MASS SPECTROMETRY;
NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;
SCREENING;
TRACE ANALYSIS;
ATOMIC EMISSION DETECTION;
DRUG PRODUCTS;
1,3 DICHLORO 5 (DIFLUOROMETHOXY)BENZENE;
BENZENE DERIVATIVE;
UNCLASSIFIED DRUG;
ACCURACY;
ATOMIC EMISSION SPECTROMETRY;
CHEMICAL ANALYSIS;
CHEMICAL STRUCTURE;
CONFERENCE PAPER;
DATA ANALYSIS;
DRUG IMPURITY;
DRUG SYNTHESIS;
GAS CHROMATOGRAPHY;
ISOLATION AND PURIFICATION;
MASS SPECTROMETRY;
NUCLEAR MAGNETIC RESONANCE;
PRIORITY JOURNAL;
|
EID: 0347284341
PISSN: 00219673
EISSN: None
Source Type: Journal
DOI: 10.1016/j.chroma.2003.10.034 Document Type: Conference Paper |
Times cited : (16)
|
References (13)
|